Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Treatment with Sequential Valproic Acid (VPA) +/− Low Doses All Trans Retinoic Acid (LoATRA) and Low Doses Ara-C (LoDAC) for “De Novo” or Relapsed Acute Myeloid Leukaemia (AML).

Susanna Fenu, MD, Clara Nervi, Carolina Nobile, MD, Anna Chierichini, MD, Paola Anticoli Borza, MD, Barbara Anaclerico, MD, Velia Bongarzoni, MD, Loredana Bove, MD, Stefania Cortese, MD, Fulivio Pauselli, MD, Carla Tozzi, MD, Su Ellen Vignetti, MD, Giuseppe G. Cimino, Luciana Annino, MD

Blood (2007) 110 (11): 4362.

https://doi.org/10.1182/blood.V110.11.4362.4362

Published: 2007

Journal Articles

High Levels of Tumor Load Reduction after Intensive Chemotherapy Favorably Affect the Prognosis of BCR/ABL+ ALL Adult Patients Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

G. Cimino, MD, L. Elia, PhD, Fabrizio Pane, MD, M. Vignetti, MD, P. Fazi, MD, S. Iacobelli, PhD, G. Meloni, MD, A. Vitale, MD, V. Martini, MD, G. Martinelli, MD, F. Di Raimondo, MD, M. Bonifacio, MD, F. Fabbiano, MD, G. Saglio, MD, M. Baccarani, MD, R. Foà, MD, F. Mandelli, MD

Blood (2006) 108 (11): 638.

https://doi.org/10.1182/blood.V108.11.638.638

Published: 2006

Journal Articles

Therapy-Related Myelodysplastic Syndrome (sMDS) /Acute Myelogenous Leukemia (sAML) in Acute Promyelocytic Leukemia (APL) Patients with Long-Lasting Molecular Remission: The GIMEMA Experience.

R. Latagliata, MD, M. Breccia, MD, P. Fazi, MD, S. Gubbiotti, MD, E. Di Bona, MD, G. Specchia, PhD, A. Chiarenza, MD, R. Murru, MD, A.M. Carella, PhD, F. Ferrara, PhD, G. Rossi, MD, L. Melillo, MD, S. Sica, MD, R. Invernizzi, MD, G. Cimino, PhD, M.C. Petti, PhD, G. Avvisati, PhD, F. Lo-Coco, PhD, F. Mandelli, PhD

Blood (2005) 106 (11): 884.

https://doi.org/10.1182/blood.V106.11.884.884

Published: 2005

Journal Articles

Long-Term Results of the GIMEMA LAP AIDA 0493 Amended Protocol in Elderly Patients with Acute Promyelocytic Leukemia (APL).

Blood (2005) 106 (11): 885.

https://doi.org/10.1182/blood.V106.11.885.885

Published: 2005

Journal Articles

Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.

C. Nervi, MD, F. Lo Coco, MD, S. Minucci, MD, A. Careddu tech., R. Fiorini, MD, E. Finolezzi, MD, N. Noguera, PHD, L. Travaglini, PHD, V. Gelmetti, PHD, D. Diverio, PHD, S. Fenu, MD, M. Mancini, MD, C. Tatarelli, MD, M.A. Aloe Spiriti, MD, M.C. Petti, MD, G. Cimino, MD, F. Mandelli, MD, S. Amadori, MD, P.G. Pelicci, MD

Blood (2004) 104 (11): 1805.

https://doi.org/10.1182/blood.V104.11.1805.1805

Published: 2004

Journal Articles

Clinical Impact of Q-RT-PCR Monitoring of Minimal Residual Disease in Newly Diagnosed Adult Patients with BCR-ABL+ Acute Lymphoblastic Leukemia Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

G. Cimino, MD, L. Elia, PHD, G. Meloni, MD, L. Annino, MD, A. Chiarenza, MD, G. Martinelli, MD, F. Pane, MD, M. Montanaro, MD, P. Chiusolo, MD, A. Santoro, MD, M. Offidani, MD, M. Vignetti, MD, G. Saglio, MD, M. Baccarni, MD, F. Mandelli, MD, Robert Foa, MD

Blood (2004) 104 (11): 1082.

https://doi.org/10.1182/blood.V104.11.1082.1082

Published: 2004

Journal Articles

Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features

M Fizzotti, G Cimino, S Pisegna, G Alimena, C Quartarone, F Mandelli, PG Pelicci, F Lo Coco

Blood (1995) 85 (10): 2685–2690.

https://doi.org/10.1182/blood.V85.10.2685.bloodjournal85102685

Published: 1995

Journal Articles

ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy

G Cimino, F Lo Coco, A Biondi, L Elia, A Luciano, CM Croce, G Masera, F Mandelli, E Canaani

Blood (1993) 82 (2): 544–546.

https://doi.org/10.1182/blood.V82.2.544.544

Published: 1993

Journal Articles

Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates

L Lin, H Londe, CV Hanson, G Wiesehahn, S Isaacs, G Cimino, L Corash

Blood (1993) 82 (1): 292–297.

https://doi.org/10.1182/blood.V82.1.292.bloodjournal821292

Published: 1993

NARROW

Treatment with Sequential Valproic Acid (VPA) +/− Low Doses All Trans Retinoic Acid (LoATRA) and Low Doses Ara-C (LoDAC) for “De Novo” or Relapsed Acute Myeloid Leukaemia (AML).

High Levels of Tumor Load Reduction after Intensive Chemotherapy Favorably Affect the Prognosis of BCR/ABL+ ALL Adult Patients Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

Therapy-Related Myelodysplastic Syndrome (sMDS) /Acute Myelogenous Leukemia (sAML) in Acute Promyelocytic Leukemia (APL) Patients with Long-Lasting Molecular Remission: The GIMEMA Experience.

Long-Term Results of the GIMEMA LAP AIDA 0493 Amended Protocol in Elderly Patients with Acute Promyelocytic Leukemia (APL).

Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.

Clinical Impact of Q-RT-PCR Monitoring of Minimal Residual Disease in Newly Diagnosed Adult Patients with BCR-ABL+ Acute Lymphoblastic Leukemia Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features

ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy

Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only